|By PR Newswire||
|August 28, 2014 11:00 AM EDT||
ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, will hold a ribbon-cutting ceremony on September 3, 2014, in Tasly's corporate offices in Rockville, MD.
The ceremony will mark the official launch of Tasly Pharmaceuticals, Inc. as the North American headquarters of Tasly Holding Group, a global technology company established in China that in May 2014 proudly celebrated its 20th anniversary.
The ceremony is expected to include over 150 distinguished guests and dignitaries, including Tasly's corporate leaders, Maryland state officials, high-level media representatives, business development executives, as well as officials from Maryland's biotechnology and pharmaceutical communities.
Tasly is pioneering the most aggressive paradigm shift in modern medicine: scientifically proving that the 5,000-year old medical practice of Modern Traditional Chinese Medicine (mTCM) – healing the body with pure, natural herbs, is as effective as treating it with chemical and synthetic drug compounds. This will fulfill an unmet clinical need for healthcare providers and patients alike by being able to treat serious diseases with chemical-free products, which could be a game changer in modern medicine.
Tasly, whose pharmaceutical products have been approved by national health regulatory authorities in no less than 34 countries worldwide, is currently undergoing the U.S. FDA Phase III Clinical Trials for its cardio-tonic pill, intended for treatment of stable angina pectoris. The revolutionary pill is expected to be the first-ever multi herb-based and chemical-free pharmaceutical product approved by the FDA.
Tasly plans to inaugurate its multi-faceted product portfolio with Deepure, Tasly's line of nutraceuticals. They encompass three condition-specific, whole-food and herb-based formulas, including ProHeart PLUS, ImmunoPower PLUS, and Pro-Memory PLUS. All Deepure nutraceuticals are gluten-free and made without chemicals, preservatives, artificial colors, flavors, sweeteners, or gelatin. Deepure will be available at leading food and drug retailer outlets nationwide, beginning this Fall.
For more information about Tasly Pharmaceuticals, Inc. and Deepure, please visit www.taslyus.com.
SOURCE Tasly Pharmaceuticals, Inc.
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
Mar. 28, 2017 09:30 PM EDT Reads: 3,695
"My role is working with customers, helping them go through this digital transformation. I spend a lot of time talking to banks, big industries, manufacturers working through how they are integrating and transforming their IT platforms and moving them forward," explained William Morrish, General Manager Product Sales at Interoute, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Mar. 28, 2017 09:30 PM EDT Reads: 3,786
With the introduction of IoT and Smart Living in every aspect of our lives, one question has become relevant: What are the security implications? To answer this, first we have to look and explore the security models of the technologies that IoT is founded upon. In his session at @ThingsExpo, Nevi Kaja, a Research Engineer at Ford Motor Company, will discuss some of the security challenges of the IoT infrastructure and relate how these aspects impact Smart Living. The material will be delivered i...
Mar. 28, 2017 09:30 PM EDT Reads: 2,196
Mar. 28, 2017 08:15 PM EDT Reads: 2,312
Mar. 28, 2017 07:00 PM EDT Reads: 4,455
Mar. 28, 2017 06:15 PM EDT Reads: 396
Mar. 28, 2017 06:15 PM EDT Reads: 362
Mar. 28, 2017 06:00 PM EDT Reads: 830
Mar. 28, 2017 04:45 PM EDT Reads: 422
Mar. 28, 2017 03:45 PM EDT Reads: 3,090
Mar. 28, 2017 03:45 PM EDT Reads: 374
Mar. 28, 2017 03:45 PM EDT Reads: 3,773
Mar. 28, 2017 03:45 PM EDT Reads: 4,118
Mar. 28, 2017 03:00 PM EDT Reads: 9,637
Mar. 28, 2017 03:00 PM EDT Reads: 2,099